GLP-2 is a synthetic peptide that acts as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, developed for advanced laboratory research. It is widely used in in vitro and animal model studies to investigate the mechanisms of metabolic regulation, particularly glucose homeostasis and lipid metabolism pathways. Researchers utilize GLP-2 to explore its binding affinity and signaling properties in cell lines and rodent models, focusing on its interactions with GIP and GLP-1 receptors under controlled conditions.